Peptide record

TPDB43861

Antiviral standard
15 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43861
Antiviral
Anti-infective peptides
AI4AVP DRAVP 2.0 Peptipedia
standard
No
A 15-aa standard-residue antiviral peptide sequence curated from AI4AVP, DRAVP 2.0, and Peptipedia, with an available 3D structural model.
Sequence
EFVLATGDFVYMSPF
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C83H115N15O23S1
RNCQHIKW
F
1722.97
3.01
0
2
9
-2
-0.36
0.833
71.33
Mammalian: 1 hour Yeast: 30 min E.coli: >10 hour
1490
0.86
3
Residue Composition
number
1
A
0
R
0
N
1
D
0
C
1
E
0
Q
1
G
0
H
0
I
1
L
0
K
1
M
3
F
1
P
1
S
1
T
0
W
1
Y
2
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 1 C: 0 E: 1 Q: 0 G: 1 H: 0 I: 0 L: 1 K: 0 M: 1 F: 3 P: 1 S: 1 T: 1 W: 0 Y: 1 V: 2
Chemical Descriptors
15 reviewed residue count
C83H115N15O23S1 sequence-only estimate (linear, free termini)
1722.97 sequence-only estimate (linear, free termini)
3.01 sequence-only estimate (linear, free termini)
-2 sequence-only estimate (linear, free termini)
-0.36 sequence-only estimate (linear, free termini)
0.833 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0